Brominated phenolic compounds (BPCs) are found in the environment, and in human and wildlife tissues, and some are considered to have endocrine disrupting activities. The goal of this study was to determine how structural differences of 3 BPC classes impact binding affinities for the thyroid receptor beta (TRb) in humans and zebrafish. BPC classes included halogenated bisphenol A derivatives, halogenated oxidative transformation products of 2,2 0 ,4,4 0 -tetrabromodiphenyl ether (BDE-47), and brominated phenols. Affinities were assessed using recombinant TRb protein in competitive binding assays with 125 I-triiodothyronine ( 125 I-T 3 ) as the radioligand. Zebrafish and human TRb displayed similar binding affinities for T 3 (K i ¼ 0.40 and 0.49 nM) and thyroxine (T 4 , K i ¼ 6.7 and 6.8 nM). TRb affinity increased with increasing halogen mass and atomic radius for both species, with the iodinated compounds having the highest affinity within their compound classes. Increasing halogen mass and radius increases the molecular weight, volume, and hydrophobicity of a compound, which are all highly correlated with increasing affinity. TRb affinity also increased with the degree of halogenation for both species. Human TRb displayed higher binding affinities for the halogenate bisphenol A compounds, whereas zebrafish TRb displayed higher affinities for 2,4,6-trichlorophenol and 2,4,6-trifluorophenol. Observed species differences may be related to amino acid differences within the ligand binding domains. Overall, structural variations impact TRb affinities in a similar manner, supporting the use of zebrafish as a model for TRb disruption. Further studies are necessary to investigate how the identified structural modifications impact downstream receptor activities and potential in vivo effects.
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Thyroid hormones (THs) are essential regulators of a range of developmental processes and physiological functions in vertebrates. Processes include fetal and postnatal growth and development, neurogenesis, metabolism, and key developmental transitions including metamorphosis and smoltification (Holzer and Laudet, 2015; Mullur et al., 2014; Pascual and Aranda, 2013; Pr eau et al., 2015) . The biological effects of THs are mediated through interactions with thyroid hormone receptors (TRs, TRa, and TRb) . TRs are members of the nuclear receptor superfamily of ligand-activated transcription factors, and serve as a link between thyroid hormones and target gene expression .
The potential for environmental contaminates to mimic native hormones and disrupt nuclear receptor (NR) signaling pathways is well established (reviewed in Zoeller et al., 2012) . Hormone binding is the molecular initiating event of many NR signaling cascades. The significance of this event is well recognized, and binding assays for steroid receptors are included in the EPA's Endocrine Disruptor Screening Program, and the OECD's conceptual framework for assessing endocrine disrupting chemicals (OECD, 2015; USEPA, 2017) . These assays are used as a screening tool to identify contaminants that directly interact with receptors, quantify the strength of that interaction, and aid in prioritizing chemicals for further analysis. Receptors such as the estrogen receptor (ER) and androgen receptor (AR) have been shown to bind a wide range of structurally diverse compounds, indicating they are vulnerable targets of many endocrine disrupting chemicals (Blair et al., 2000; Fang et al., 2003; Laws et al., 2006) .
In contrast, TRa and TRb are highly specific and selective for thyroid hormones. The size, geometry, and chemical properties of the ligand-binding pocket (LBP) closely match the hormones. Previous binding studies that tested a structurally diverse range of common endocrine disrupting chemicals revealed that compounds that deviate from the molecular attributes and physicochemical properties of thyroid hormones are excluded from binding (Ishihara et al., 2003a,b) . Despite the high receptor selectivity, halogenated phenolic contaminants that share features and physicochemical properties with thyroid hormones may bind and disrupt TR signaling. However, the current data regarding the influence of chemical structure on TR affinity are unresolved and suggest the possibility of species differences, particularly between mammalian and nonmammalian vertebrates.
Studies examining the affinities of halogenated contaminants to mammalian TRs (human and rat) suggest a strong preference for a hydroxylated diphenyl core structure similar to that of thyroid hormones. For example, OH-PBDEs bound TRs with affinities ranging from 10 À7 to 10 À4 M, but the parent PBDEs lacked affinity (Kitamura et al., 2005a (Kitamura et al., , 2008 Ren et al., 2013) . The binding affinities were additionally influenced by the position of the hydroxyl group and halogenation pattern. Specifically, at least 1 aromatic ring of the compounds with the highest affinity for TR were substituted similar to the outer ring of thyroxine (T 4 ): a para hydroxyl group (4-OH) with adjacent halogens on each side (Kitamura et al., 2005a (Kitamura et al., , 2008 . Single-ring structures such as 2,4,6-tribromophenol (TBP), tetrabromohydroquinone (TBHQ), and the herbicide acetochlor also lacked TR affinity (Kitamura et al., 2008) . Binding assays with halogenated bisphenol A (BPA) compounds and TRs isolated from a rat pituitary cell line found that halogen species influenced affinities, as tetrabromobisphenol A bound with higher affinity than tetrachlorobisphenol A (Kitamura et al., 2005b) , possibly due to bromine being more chemically similar to iodine than chlorine. A study by Ren et al. (2013) demonstrated that the increasing the degree of bromination on the aromatic rings of OH-PBDEs increased their affinity for human thyroid receptor beta (TRb), likely due to increased ligand-receptor hydrophobic interactions. Compared with mammalian TRs, binding studies using nonmammalian TRs are limited. To date, nonmammalian studies have included TRb orthologs from 2 amphibians and 2 birds: the African clawed frog (Xenopus laevis), bullfrog (Rana catesbeiana), chicken (Gallus gallus), and Japanese quail (Coturnix japonica) (Ishihara et al., 2003a,b; Kitamura et al., 2005b; Kudo and Yamauchi, 2005; Kudo et al., 2006; Yamauchi et al., 2003) . Similar to human and rat, TRs from nonmammalian vertebrates display a preference for a hydroxylated diphenyl core, whereas compounds that diverge from this core structure lack affinity (Ishihara et al., 2003a,b) . This includes compounds such as PAHs, alkylphenols, phthalates, and biocides such as organophosphates and chloroacetanilides. Studies with brominated and chlorinated BPAs and Xenopus TRb imply nonmammalian TRs prefer bromine over chlorine (Kudo and Yamauchi, 2005; Kudo et al., 2006) . However, unlike the study by Ren et al. (2013) with rat TRs, increasing halogenation did not increase binding affinity for Xenopus TRb. 3,3 0 -dibromobisphenol A had the highest affinity for Xenopus TRb of the brominated BPA compounds, followed by 3,3 0 ,5-tribromobisphenol A and 3,3 0 ,5,5 0 -tetrabromobisphenol A (TBBPA) (Kudo et al., 2006) . Of the chlorinated bisphenol A compounds, 3,3 0 ,5-trichlorobisphenol A had the highest affinity for Xenopus, bullfrog and chicken TRs, however, the pattern between species varied for additional chlorinated BPAs (Kudo and Yamauchi, 2005; Yamauchi et al., 2003) . These results suggest there may be differences in ligand preferences between mammalian and nonmammalian TRs. As exposure to many halogenated contaminants is widespread and a concern for both human and ecosystem health, species differences in ligand preferences may have important implications for hazard assessments. The goal of this study was to examine how structural modifications of 3 brominated phenolic compound classes (BPCs) impact the potential of these compounds to bind TRb using competitive binding assays. We focused primarily on structural variations of 3,3 0 ,5,5 0 -tetrabromobisphenol A (TBBPA), 2,4,6-tribromophenol (TBP), and the oxidative transformation products of BDE-47 (OH-BDE-47). TBBPA is the highest production volume brominated flame retardant (BFR) currently in use, with almost 120 million pounds produced in 2011 (USEPA, 2012) . TBBPA is a tetrabrominated analog of bisphenol A that is used as a flame retardant in electronic circuit boards and plastics, but also has applications in art supplies, textiles, and children's toys (Covaci et al., 2009; USEPA, 2015) . Polybrominated diphenyl ether (PBDE) mixtures were used as flame retardants for decades in products containing polyurethane foam, such as furniture, mattresses, and carpeting. BDE-47 is the most abundant PBDE congener found in human tissues (Leonetti et al., 2016; Stapleton et al., 2011 Stapleton et al., , 2012 , and serum concentrations of the oxidative transformation products of BDE-47 (OH-BDE-47) are found at higher concentrations than other OH-BDEs in humans, marine mammals, and fish (De la Torre et al., 2013; Houde et al., 2009; Nomiyama et al., 2011a,b; Qiu et al., 2009; Valters et al., 2005) . PBDE use has been phased out or banned in many countries, however, exposure is expected to continue due to long-term product use and recycling. 2,4,6-tribromophenol has multiple applications, including as a wood preservative, intermediate in synthesis of other BFRs, and BFR metabolite or degradation by-product (Qiu et al., 2009; Suzuki et al., 2008) . The structural analogs included in this study were chosen primarily based on specific structural differences between the analogs and the 3 BPC compounds, and their environmental relevance. Differences include halogen species, degree of halogenation, presence/absence of halogens and/or hydroxyl groups, chemical backbones, and number of aromatic rings. For this study, a comparative approach was applied by including TRb orthologs from human and zebrafish to further our understanding of the influence of chemical structure on TRb affinities in mammalian and nonmammalian species. This initial study focused on TRb for multiple reasons. Like most vertebrates, humans have a single gene for both TRb and TRa. Zebrafish also have a single TRb gene, however, zebrafish and other teleost fish species maintain 2 TRa genes as a result of a whole genome duplication event that took place early in the evolution of teleost fish (Bertrand et al., 2007; Meyer and Van de Peer, 2005) . The evolutionary fate of duplicate genes can vary: 1 copy can evolve a novel function, the functions of the original gene can be divided between the 2 paralogs, or 1 paralog may become nonfunctional while the other retains the original function (reviewed in Hahn, 2009) . As the potential functional differences of the TRa paralogs in fish are not well characterized, we chose to focus on TRb to better enable a comparison between species. Furthermore, previous work from our lab has suggested a potential role for TRb in thyroid endocrine system disruption in zebrafish (Dong et al., 2014; Macaulay et al., 2015) . Finally, we chose TRb to facilitate comparisons with previous studies in nonmammalian vertebrates that focused on the TRb ortholog from their respective species (Ishihara et al., 2003a,b; Kudo and Yamauchi, 2005; Kudo et al., 2006; Yamauchi et al., 2003) .
Zebrafish are a popular model species for vertebrate development due to a high degree of conservation of many endocrine signaling pathways between zebrafish and mammals, despite the fact that the 2 lineages diverged roughly 450 Ma (Kumar and Hedges, 1998) . The hypothalamus-pituitary-thyroid (HPT) axis is highly conserved, and the major components of the thyroid system have been identified in zebrafish, including thyroid hormone receptors (Blanton and Specker, 2007; Heijlen et al., 2013; Liu et al., 2000; Porazzi et al., 2009; Walpita et al., 2007) . For these reasons zebrafish and other small fish have become increasingly popular models of thyroid related disease and disruption (Macaulay et al., 2015; Noyes et al., 2013; Rald ua et al., 2012; Thienpont et al., 2011) . However, studies examining TRmediated effects of these compounds in zebrafish are limited. A clearer understanding of how chemical structure impacts TRb function will better enable scientists to predict receptormediated effects of potential endocrine disruptors and aid in understanding potential human and ecosystem health effects. (Liu et al., 2000) . The sequence was PCR amplified using Titanium Taq DNA polymerase (Clontech, Mountain View, California) following the manufacturer's protocol. The primer sequences with incorporated restriction sites are listed in Supplementary Table  2 . The PCR product was gel-purified and ligated into the pGEM-T Easy Vector (Promega, Madison, Wisconsin) following the manufacturer's protocol. The ligated construct was transformed into Subcloning Efficiency DH5a Competent Escherichia coli (Invitrogen, Carlsbad, California), and positive clones were identified via a blue/white screen. DNA constructs were isolated and sequenced to confirm gene identity. The TRb sequence was subcloned into the pET32a(þ) protein expression vector (Merck Millipore, Darmstadt, Germany) via the NspV (5 0 ) and XhoI (3 0 ) restriction sites. The construct was transformed into Rosetta2(DE3)pLysS chemically competent Escherichia coli (Merck Millipore, Darmstadt, Germany) for protein expression. Sequence integrity and orientation was verified by sequencing in both directions. The protein size was 49.4 kDa including the pET32a vector tags.
MATERIALS AND METHODS

Chemicals
Human TRb. The ligand binding domain of the human TRb (GenBank ID HQ692825.1) corresponding to amino acids No. 202-462, was codon-optimized for expression in Escherichia coli, and assembled from synthetic oligonucleotides and/or PCR products. The synthetically prepared gene was created and inserted into the pET32b(þ) protein expression vector via the NcoI ( 5 0 ) and BamHI (3 0 ) restriction sites by GeneArt (ThermoFisher Scientific, Waltham, Massachusetts). DNA sequencing verified construct integrity, and 5 mg of the plasmid preparation were lyophilized prior to shipping from GeneArt. Upon receipt, the DNA was reconstituted in sterile water and transformed into TOP10 and BL21(DE3)pLysS chemically competent Escherichia coli bacteria (Merck Millipore, Darmstadt, Germany). The protein size was 46.6 kDa including vector tags.
Sequence Analysis
Vertebrate TRb sequences were obtained through the Basic Local Alignment Search Tool (BLAST) of the National Center for Biotechnology Information (URL: www.ncbi.nih.gov/Blast.cgi; last accessed August 28, 2017). The ligand binding domains within the TRb amino acid sequences were identified and aligned using ClustalW (Thompson et al., 1994) Nascimento et al., 2006; and 1XZX, Sandler et al., 2004) .
Protein Expression
For zebrafish TRb protein expression, a single bacteria colony from a freshly streaked plated was used to inoculate 10 ml of lysogeny broth (LB/carb: 1% wt/vol tryptone, 0.5% wt/vol yeast extract, 1% wt/vol NaCl, 100 mg/ml carbenicillin, 34 mg/ml chloramphenicol, pH 7.4), and grown overnight at 37˚C with vigorous shaking (200 rpm). The following morning, 500 ml of fresh LB/ carb (500 ml) was inoculated with the starter culture, and incubated at 37˚C with shaking (200 rpm) until the OD 600 %0.6. The temperature was decreased to 18˚C, and protein expression was induced with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG, Apex Biosciences, Chapel Hill, North Carolina). The culture was incubated for an additional 3 h at 200 rpm. For human TRb protein expression, a 20-ml starter culture was used to inoculate 1 l of autoinduction media (1% wt/vol tryptone, 0.5% wt/ vol yeast extract, 2 mM MgSO 4 , 6 mM lactose, 3 mM glucose, 0.5% vol/vol glycerol, 25 mM (NH 4 ) 2 SO 4 , 50 mM KH 2 PO 4 , 50 mM Na 2 HPO 4 , 25 mg/ml carbenicillin). The autoinduction culture was incubated at 28˚C overnight with shaking at 250 rpm. Following expression, both cultures were pelleted by centrifuging at 4000 rpm at 4˚C for 20 min. The supernatants were discarded, and the pellets were stored at À20˚C until protein purification.
Protein Purification Zebrafish TRb. Frozen bacteria pellets were thawed on ice, and resuspended in 50 ml of lysis buffer (40 Branson Ultrasonics, Danbury, CT). The cell debris was pelleted by centrifuging the lysate at 12 000Âg at 4˚C for 10 min. The pellet was discarded and the supernatant containing the soluble zebrafish TRb protein was purified using immobilized metal affinity chromatography (IMAC) on a BioLogic HR FPLC system kept at 4˚C (Bio-Rad Laboratories, Hercules, California). The concentrations of NaCl and imidazole were increased to 500 mM and 25 mM prior to purification. The lysate was loaded onto a Ni-NTA column (HisTrap FF 1.0 ml, GE Healthcare Life Sciences, Pittsburgh, Pennsylvania) pre-equilibrated with binding buffer (40 mM Na 2 HPO 4 , 10mM NaH 2 PO 4 , 500 mM NaCl, 10% glycerol, 0.2% Tween-20, 15 mM b-mercaptoethanol, 1 mM PMSF, 25 mM imidazole, pH 7.4). The column was washed with binding buffer, and the polyhistadine-tagged TRb protein was eluted by gradually increasing the concentration of imidazole from 25 mM to 400 mM. Protein elution was monitored by UV-Vis chromatography (280 nm). The fractions containing zebrafish TRb were combined and concentrated using a Microsep Advance Centrifugal Device (Pall Corporation, Ann Arbor, Michigan) following the manufacturers protocol. Concentrated protein was divided into single-use aliquots (20 ml) in PCR tubes and flash-frozen in liquid nitrogen (Deng et al., 2004) , and stored at À80˚C. Protein purity and integrity was assessed via SDS-PAGE (Supplementary Figure 2) , and protein concentration was quantified via a Bradford assay (Pierce Protein Biology, ThermoFisher Scientific, Waltham, MA).
Human TRb. Recombinant human TRb protein was purified using IMAC followed by anion exchange chromatography on an € AKTA avant FPLC system (GE Healthcare Bio-Sciences, Uppsala, Sweden) in a cold room kept at 4˚C. Frozen bacteria pellets were thawed on ice and resuspended in 100 ml lysis buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 10 mM imidazole, cOmplete EDTA-free protease inhibitor cocktail tablets [Roche Diagnostics, Mannheim, Germany], 10 U/ml DNaseI, pH 7.4). The suspension was rotated gently at 4˚C for 15 min before passing through a M-110 P microfluidizer (Microfluidics Corp, Westwood, Massachusetts) at 15 000 psi to lyse the cells. The lysate was collected and centrifuged at 15 000 rpm for 20 min at 4˚C. The insoluble fraction was discarded and the supernatant containing the soluble human TRb protein was loaded onto a 5-ml HisTrap FF column pre-equilibrated with binding buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 10 mM imidazole, pH 7.4). The column was washed with binding buffer, and the polyhistadine-tagged human TRb was eluted by gradually increasing the concentration of imidazole from 10 mM to 500 mM. Protein elution was monitored by UV-Vis chromatography (280 nm). The eluted fractions containing human TRb were combined and diluted 15-fold into anion exchange binding buffer (20 mM Tris, pH 7.4) containing cOmplete EDTA-free protease inhibitor cocktail tablets. The diluted sample was loaded onto a HiTrap Q HP 5 ml anion exchange column (GE Healthcare Bio-Sciences, Uppsala, Sweden) pre-equilibrated with binding buffer. The column was washed with binding buffer, and human TRb protein was eluted by gradually increasing the concentration of NaCl from 0 to 1 M. The protein elution was monitored by UV-Vis chromatography (280 nm). The eluted fractions containing the human TRb protein were combined and dialyzed into 50 mM Tris, 50 mM NaCl, pH 7.4 for 2 h at 4˚C using a 10 MWCO Slide-a-Lyzer cassette (ThermoFisher Scientific, Waltham, MA). Glycerol was added to the dialyzed product at a final concentration of 10% vol/vol prior to flash-freezing single-use aliquots in liquid nitrogen for storage at À80˚C. The protein purity and integrity was assessed by SDS-PAGE (Supplementary Figure 2) and the protein concentration was quantified by the bicinchoninic acid (BCA) assay (Pierce Protein Biology, ThermoFisher Scientific, Waltham, MA).
Saturation Binding Assays
Optimal receptor concentrations for the binding assays were determined with protein titration curves (Supplementary Figure  3) . For the saturating binding assays, each 100 ml reaction contained 10 nM purified zebrafish TRb or 40 nM human TRb in binding buffer (40 mM Na 2 HPO 4 , 10 mM NaH 2 PO 4 , 150 mM NaCl, 10% glycerol, 15 mM b-mercaptoethanol, pH 7.4) and 0-10 nM of [ Reactions were incubated at 4˚C overnight (approximately 18 h). Bound ligand was separated from free using the charcoal adsorption method (Strange, 1992) : 100 ml of a 1.6% dextran: activated charcoal (1:10 wt/vol) solution in separation buffer (40 mM Na 2 HPO 4 , 10mM NaH 2 PO 4 , 150 mM NaCl, 0.1% gelatin, 0.02% NaN 3 , pH 7.4) was added to each tube and incubated on ice for 15 min with gentle shaking every 5 min. The reaction tubes were centrifuged at 4000 rpm for 15 min at 4˚C to pellet the charcoal suspension. A 100-ml aliquot of the supernatant containing the receptor-bound ligands was removed for scintillation counting. Data were globally analyzed in GraphPad Prism 7 (GraphPad Software Inc, La Jolla, California) using a one-site binding model for total and nonspecific binding. Each curve was repeated 3 times with duplicate tubes per concentration. The reported affinity (K d ) is the average of the 3 curves 6 SEM. Between species comparisons were made using Welch's t-test in GraphPad Prism 7 (GraphPad Software Inc, La Jolla, CA).
Competitive Binding Assays
Competitive binding assays included at least 10 competitor concentrations for individual chemicals. As described for the saturation curves, each 100 ml reaction included 10 nM recombinant zebrafish TRb or 40 nM recombinant human TRb in binding buffer. Additionally, each tube contained 3 nM of [ 125 I]-T 3 and a range of competitor concentrations (0-1 mM, depending on competitor solubility). Competitor stocks were made in 100% DMSO, and assay dilutions were made in binding buffer.
Nonspecific binding reactions included 1 mM of unlabeled T 3 . Reactions were incubated overnight, and receptor-bound ligand was separated from free and counted as described earlier. Specific binding was determined by subtracting the average of the nonspecific binding counts from the total binding counts. Data were analyzed in GraphPad Prism 7 (GraphPad Software Inc, La Jolla, CA). Sigmoidal curves were initially fit to the raw CPM values to identify the top and bottom plateaus. Data were then normalized to the top plateau (100% bound) and bottom plateau (0% bound) in GraphPad. In the absence of a bottom plateau, data were normalized to the NSB control. The affinity for the competitor (K i ) was determined using a one-site binding model in GraphPad Prism 7 (GraphPad Software Inc, La Jolla, CA). Each competition curve was repeated 3 times with 3 tubes per dose. The reported affinity for each chemical is the average of the 3 curves. To more accurately represent the true variance in the combined data sets, the SD was calculated from the grand variance of all 3 replicates for each dose. The grand variance was calculated from the total sum of squares of the individual values from the 3 reps divided by the degrees of freedom for each dose. The calculated SD is the square root of this number. Between species comparisons were made using Welch's t-test in GraphPad Prism 7.
Correlations
Physicochemical properties were taken from SciFinder (scifinder.cas.org; last accessed March 21, 2017). Spearman rank correlation coefficients were calculated in GraphPad Prism 7 (GraphPad Software Inc, La Jolla, CA) using log-transformed K i values. Statistical significance was set at a¼.5.
RESULTS
Thyroid Receptors
The multiple sequence alignment revealed that the shared sequence identities of the TRb LBDs ranged between 86% and 99%, indicating a high degree of conservation across species and vertebrate evolution (Figure 1 and Supplementary Table 3) . The zebrafish TRb LBD was 90% identical to human TRb LBD. Zebrafish TRb was most like human TRb compared with the other 4 fish, whereas medaka was the least similar to human (86%). Sequence identities shared between zebrafish TRb and the other fish species were slightly higher compared with human TRb, and ranged from 91% to 95%. The shared identity between zebrafish and rat (90%), chicken (92%), and frog (93%) were within the ranges observed with human and the other fish species.
The 9 TRb LBD sequences were compared with previously annotated human TRb sequences, and essential features were identified (Nascimento et al., 2006; Sandler et al., 2004; Wagner et al., 1995) . Amino acid residues involved in TRb-T 3 interactions were conserved across species (Figure 1 ). The 12 a-helices (H1-H12) and 4 b-strands (S1-S4) were identified, and are highly conserved. Of the 246 amino acids of the LBDs, only 23 varied between human and zebrafish. Most of the amino acid variation is located between H1 to the beginning of H3, and H9 to before the start of H11. As noted previously, zebrafish TRb lack the 9 amino acid insert that is present in other fish species, but absent in humans and other vertebrates (Liu et al., 2000; Nowell et al., 2001) .
Assay Optimization and Performance: Thyroid Hormones
Protein titration experiments indicated that the optimal receptor concentrations for the binding assays were 10 nM for zebrafish TRb and 40 nM for human TRb (Supplementary Figure 3) .
Receptor concentrations were assigned based on the following criteria: 1) nonspecific binding was 20% of total binding, 2) 10% or less of the total amount of [ 125 I]-T 3 added was bound at receptor saturation to avoid issues with ligand depletion, and 3) a Z'-factor ! 0.6, which indicates the receptor concentration yields a good dynamic range between NSB and total binding. The Z'-factors were 0.8 for human TRb and 0.9 for zebrafish TRb.
Saturation binding curves were first conducted to determine the affinity of the receptors for the native ligand (T 3 ) and to identify the saturating concentration range of [ 125 I]-T 3 for use in the competitive binding assays (Figure 2A ). An unpaired t-test with Welch's correction indicated that the affinities of [ 125 I]-T 3 for zebrafish TRb (K d ¼ 0.60 6 0.11 nM) and human TRb (K d ¼ 0.71 6 0.13 nM) were not significantly different between species (p ¼ .58). The affinities were comparable with previously reported affinities for multiple nonmammalian vertebrates, including fish (sea bream: 0.625 nM, and tilapia: 0.2 nM), quail (0.31 nM), chicken (0.63 nM), and bullfrog (0.76 nM), as well as previously reported affinities for mammalian TRb including rat (0.49 nM) and human (0.14 nM) (Ishihara et al., 2003a,b; Mendoza et al., 2013; Nowell et al., 2001; Togashi et al., 2005; Williams, 2000) .
The competitive binding assays were optimized and validated using unlabeled thyroid hormones as competitors ( Figure 2B 
Tetrabromobisphenol A and Related Compounds
All tested bisphenols competed with T 3 and bound TRb in a concentration-response manner, however, the affinities of each compound for TRb ranged between 10 À8 and 10 À4 M. The competitive binding curves are depicted in Figures 3A-C, and Table 1 lists the binding affinity (K i ), 95% confidence interval, and statistical results for affinity comparisons between species. The binding curves for the 3,3 0 ,5,5 0 -tetrasubstituted bisphenols in Figure 3A illustrate the role of halogen species on TRb affinities. Of the 3 tetrahalogenated bisphenol A compounds (TCBPA, TBBPA, TIBPA), the binding curve shifts left with increasing halogen size and weight, indicating the affinity for TRb is increasing. TIBPA had the highest affinity of all the compounds tested, and the affinity was only approximately 12Â lower than T 4 for both species. The TIBPA affinities were not significantly different between species (p ¼ .883), however, the affinity for zebrafish TRb was significantly lower than human TRb for TBBPA (p ¼ .026) and TCBPA (p ¼ .028). Replacing the dimethylmethylene bridge of TBBPA with a sulfone (TBBPS) decreased TRb affinity by over 10Â for zebrafish and 30Â for human. TBBPA and TMBPA have identical molecular volumes (Supplementary Table 1) , however, replacing the bromines with methyl groups decreased TRb affinity 12Â for zebrafish and 6Â for human TRb.
Results in Figure 3B demonstrate that TRb affinity increased with increasing levels of bromination. TBBPA had the highest affinity for human TRb (K i ¼0.22 mM), followed by 3,3 0 ,5-BrBPA (0.28 mM), 3,3 0 -BrBPA (0.82 mM), 3-BrBPA (3.34 mM), and BPA (33.3 mM). Zebrafish TRb affinities followed the same pattern, however, the affinities were lower than for human TRb: TBBPA (K i ¼0.53 mM) > 3,3 0 ,5-BrBPA (1.42 mM) > 3,3 0 -BrBPA (4.42 mM) > 3-BrBPA (16.9 mM). BPA was a nonbinder for zebrafish TRb. A similar pattern was also observed for the methylated bisphenol A compounds ( Figure 3C ). TMBPA had the highest affinity for both species (K i ¼6.5 mM for zebrafish TRb and 1.33 mM for human TRb), followed by DMBPA (K i ¼13.7 and 4.6 mM, respectively).
Replacing the dimethylmethylene bridge of TBBPA with a sulfone (TBBPS) decreased binding affinities for both species, however, species differences were observed for the nonbrominated core structures BPA and BPS ( Figure 3C ). Similar to TBBPA and TBBPS, human TRb bound BPS with a 2.2Â lower affinity than BPA. Zebrafish TRb maintained a similar affinity for BPS as human TRb, however, BPS has a higher affinity for zebrafish TRb than BPA, as the nonsigmoidal shape of the curve indicates that BPA was a nonbinder for zebrafish. Replacing the methyl groups on the methylene bridge of BPA with trifluoromethyl groups (BPAF) increased affinity 28Â for human, and resulted in binding affinity for zebrafish ( Figure 3C ).
Hydroxylated BDE-47 and Related Compounds 3-OH-BDE-47 and 6-OH-BDE-47 bound both receptors with submicromolar affinity ( Figure 4A and Table 1 ). The K i for 3-OH-BDE-47 was 0.21 mM for zebrafish TRb and 0.27 for human TRb. For 6-OH-BDE-47, the K i values were 0.31 mM for zebrafish and 0.54 mM for human TRb. The affinity of triclosan, a hydroxylated trichlorodiphenyl ether, was an order of magnitude lower compared with the brominated compounds (K i ¼ 4.06 mM for human TRb, and 4.65 mM for zebrafish TRb Figure 4A ). BDE-47, the nonhydroxylated PBDE congener, was unable to compete with [ 125 I]-T 3 and bind TRb at any tested concentration.
2,4,6-Tribromophenol and Related Compounds
Unlike the halogenated bisphenols, the halogenated phenols displayed different affinity patterns between species with regards to halogen size. The affinity of the trihalogenated phenols for human TRb increased with halogen molecular weight and atomic radius ( Figure 4B ): TFP (no affinity) < TCP (K i ¼ 56 mM) < TBP (30.6 mM) < TIP (1.69 mM). However, the affinity for zebrafish TRb did not follow the same pattern: TFP (K i ¼ 58.26 mM) < TBP (31.28 mM) < TCP (13.68 mM) < TIP (2.68 mM). The affinity between species was not significantly different for TIP and TBP, however, the affinity of TCP for zebrafish TRb was over 4Â higher than human TRb (p ¼ .013). Similar to the brominated bisphenols, TRb affinity increased with increasing degree of bromination. The affinity of pentabromophenol for TRb was 26Â (zebrafish) and 15Â (human) higher than TBP.
Correlations with Physicochemical Properties
Spearman correlations were conducted to compare binding affinities to select physicochemical properties of the test compounds (Figs. 5A-C) . Affinity for zebrafish TRb was negatively correlated with molecular weight (r¼À0.84, p < .001), molar volume (r¼À0.21, p ¼ .023), and log K OW (r¼À0.85, p < .001). Human TRb affinity was also negatively correlated with molecular weight (r¼À0.71, p < .001), molar volume (r¼À0.68, p ¼ .001), and log K OW (r¼À0.85, p < .001). The affinities between the 2 receptors were also correlated (r ¼ 0.86, p < .001) ( Figure 5D ).
DISCUSSION
Brominated phenolic contaminants have long been known to disrupt the thyroid endocrine system, however, the potential of these compounds to disrupt TR-mediated gene expression is currently unresolved. This study assessed how structural variations of 3 common BPCs impact binding affinity for TRb. As BPCmediated thyroid disruption is a concern for both humans and wildlife, a comparative approach was applied by selecting receptors from 2 distantly related species: human and zebrafish. Zebrafish are a popular model for vertebrate development and thyroid disruption, with relevance to both human and ecosystem health. Overall, both receptors displayed similar ligand selectivity and specificity for the test compounds, and the ligand affinities for each receptor were highly correlated (r ¼ 0.86, p < .001). However, some species-specific differences in ligand affinity were observed. The K i values for 9 of the 22 test compounds were significantly different between species. Eight of these compounds had significantly higher affinities for human TRb compared with zebrafish, and all 8 were part of the TBBPA group. The affinity of the ninth compound, TCP, was significantly higher for zebrafish TRb over human. In addition, TFP has a higher affinity for zebrafish TRb as it did not bind human, whereas the opposite was observed for BPA, which bound human TRb but not zebrafish. The fact that the 2 receptors display divergent affinities for a select group of compounds yet highly conserved affinities for thyroid hormones is intriguing. The molecular interactions driving the differential affinities is currently unknown, however, there are several potential possibilities involving species-specific differences within the LBD.
The LBDs of zebrafish and human differ by 23 amino acids. Most of these differences occur between H1 to the beginning of H3, and H9 to between H10 and H11 (Figure 1) . The physicochemical properties of the species-specific amino acids may method. Data were normalized to the top (100% bound) and bottom (0% bound) plateaus. In the absence of a bottom plateau, data were normalized to the nonradioactive T 3 control. The affinity of the bisphenol competitor (K i ) was determined via nonlinear regression using a one-site binding model. The reported K i and 95% confidence intervals were calculated from the average of 3 curves.
influence the tertiary protein structure of the receptor and the chemical nature of the LBP. The resulting effects on receptor structure would likely be minor or localized to avoid disrupting interactions with thyroid hormones. However, minor structural changes may be enough to enable human TRb to better accommodate the larger bisphenols, whereas zebrafish TRb may be better able to tightly pack around the smaller halogenated phenols. Aside from altering receptor structure, the amino acid variations within the LBPs may lead to novel ligand-receptor interactions with the tested BPCs that are absent in interactions with native thyroid hormones. For example, the LBPs of human TRa and TRb differ by 1 amino acid: serine-277 of TRa is an asparagine (N331) in TRb. Asparagine increases the stability of the hydrogen bond formed with the carboxylate of the synthetic thyromimetic GC-1, and increased affinity and selectivity of GC-1 for TRb over TRa (Bleicher et al., 2008) .
Despite the observed affinity differences, both receptors responded in a similar manner to the structural changes. The structural feature that had the largest impact on binding affinities was halogenation. Thyroid hormones are one of the few biogenic ligands that are halogenated, and it has been hypothesized that the iodines play an active role in ligand-receptor interactions (Valadares et al., 2009) . In general, we observed that TRb affinity increased with increasing halogen mass and atomic radius (F < Cl < Br < I) for both species, with the iodinated compounds (TIBPA and TIP) having the highest affinity within their compound classes. Increasing halogen mass and atomic radius increases the molecular weight, volume, and hydrophobicity of a compound, which are all highly correlated with increasing affinity (Figs. 5A-C) .
Increasing the degree of halogenation also positively influenced affinity for TRb from both species, as is evident with the brominated bisphenols. The addition of a single bromine onto C3 of BPA increased affinity for TRb by approximately 10Â for both species, and affinity increased with each subsequent bromine. We originally hypothesized that 3,3 0 ,5-tribromobisphenol A would have the highest affinity of the brominated BPAs, as this compound is most analogous to T 3 from a halogen substituent configuration standpoint. However, our results show that TBBPA, which is more analogous to T 4 , had the highest affinity. The effect of an additional bromine on TBBPA vs. 3,3 0 ,5-tribromobisphenol A may help compensate for the shorter length of the molecule compared with T 3 . The role of halogen size and number in determining binding affinity was also evident for the halogenated phenols. At first, the halogenated phenols were not expected to have affinity for TRb due to the fact that TBP has been previously shown to lack affinity for amphibian and rat TRb (Kitamura et al., 2008; Kudo et al., 2006) . In contrast to previous studies, our results demonstrate that TBP and other halogenated phenols bound TRb, albeit with generally lower affinities compared with larger diphenyl compounds such as the halogenated bisphenols. In addition, affinity increased with increasing halogen mass, volume, and degree of halogenation, and helped compensate for the smaller size of the compound. For example, the affinity of zebrafish TRb for PBP and TIP was in the same range as TCBPA, whereas human TRb affinity for both compounds was comparable with BPAF and 3-BrBPA.
Although halogenation appears to greatly influence TRb binding affinities, the exact mechanisms of action is not completely understood. Halogens have long been considered merely electronegative and hydrophobic moieties that did not directly participate in ligand-protein interactions. However, studies in the past decade have yielded an intriguing possibility: that halogens play an active role in ligand affinities by directly interacting with receptors and other proteins through the formation of halogen bonds (X-bonds) (reviewed in Politzer et al., 2010; Scholfield et al., 2013; Wilcken et al., 2013) . Halogen bonds are noncovalent, electrostatic, and directional interactions between a region of positive electrostatic potential on the halogen opposite the R-X covalent bond and an electronegative Lewis base (O, N, S) on the receptor. They are highly directional (!160˚), and their distance is less than the sum of the van der Waals radii for the 2 molecules. Although halogens are considered electronegative substituents, the distribution of electrostatic potential across the halogen's surface is not uniform. The polarizability and electronegativity of the halogen, as well as the electron-withdrawing ability of nearby functional groups, can result in an area of positive charge on the halogen directly opposite the X-C covalent bond. This positive region (referred to as a r-hole) may form a noncovalent and electrostatic interaction with a nearby negative site on the receptor, thus contributing to the strength and selectivity of the ligand-receptor interactions.
Halogen bonds have been identified in numerous biological systems in recent studies and through retrospective surveys of protein databases, including proteins involved in the thyroid endocrine system. The thyroid hormone transport protein transthyretin (TTR) has been shown to form halogen bonds with the 3 0 -iodine and 5 0 -iodine of T 4 in numerous species (Eneqvist et al., 2004; Wojtczak et al., 2001) . Deiodinases form halogen bonds with the iodines of thyroid hormones to aid in cleaving the carbon-iodine bond when converting T 4 to T 3 (Manna et al., 2015) . Additionally, a recent QSAR study identified a halogen bond between F272 of TRb and the 3-I of T 3 or 3-Br of brominated T 3 analogs (PBD codes 1XZX and 2J4A) (Valadares et al., 2009) . Most studies thus far have been limited to thyroid hormones, but they suggest the possibility that additional halogenated phenolic compounds may form halogen bonds with thyroid hormone proteins. Although the current data are limited, it is possible that halogen bonds may play a significant role in determining the TRb affinities of halogenated phenolic compounds, and is worthy of further exploration. The current results with TBBPA and TBBPS, as well as BPA, BPS, and BPAF indicate that the bridge group of the diphenyl compounds have a role in determining TRb affinities. The ether bridge of thyroid hormones is not directly involved in hormonereceptor interactions, but instead is responsible for maintaining the correct bond angle and perpendicular orientation of the 2 aromatic rings relative to each other, which aids in determining the fit of the ligand in the LBP (de Araujo et al., 2010; Luthe et al., 2008) . Within the diphenyl structures tested, the aromatic rings were bridged by either an ether, a dimethylmethylene, or a plateaus. In the absence of a bottom plateau, data were normalized to the nonradioactive T3 control. The affinity of each competitor (Ki) was determined via nonlinear regression using a one-site binding model. The reported Ki and 95% confidence intervals were calculated from the average of 3 curves.
sulfone. The current results support the notion that ring orientations that diverge from that observed for T 3 may negatively impact binding affinities, as illustrated by the results with TBBPA and TBBPS. Both compounds are tetrabrominated bisphenols, however, the aromatic rings of TBBPS are linked by a sulfone instead of a dimethylmethylene group of TBBPA. Like T 3 , the 2 rings of TBBPA are perpendicular to each other in a 'twist' conformation. The sulfone linkage of TBBPS orients the 2 rings 'face to face' rather than perpendicular as in T 3 and TBBPA (Sakai et al., 2009) . The significantly lower affinity of TBBPS compared with TBBPA is potentially due to the suboptimal ring orientation and position of TBBPS within the LBP, thus disrupting essential ligand-receptor interactions. Although BPA was able to compete with [ 125 I]-T 3 and bind human TRb (albeit with very low affinity), the cause of the irregular nonsigmoidal BPA curve for zebrafish TRb is not clear. Irregular binding curves typically occur due to reasons unrelated to true competitive binding, such as test compound precipitation, interference with charcoal adsorption, or protein denaturation (Freyberger and Ahr, 2004; Hornung et al., 2017; Laws et al., 2006) . Nonsigmoidal curves display a variety of characteristics including a U-shape or inverted U-shape, a steep slope, and plateau before full competition takes place. Hormone binding > 100% has been observed previously with other nuclear receptors, and was found to be due to nonreceptor mediated effects that compromised the integrity and stability of the assay (Blair et al., 2000; Hornung et al., 2017) . The current results suggest the issue is specific to the zebrafish TRb protein and BPA, as this curve shape was not observed with human TRb or any other test compounds. Considering that the only variable between the human and zebrafish assays is the receptor protein, it is unclear why BPA would disrupt the zebrafish curve and not human. Further work is necessary to determine the true cause of the nonsigmoidal curve.
One of the greatest strengths of binding assays is also a major limitation: binding assays only determine if a compound interacts with a receptor of interest, and quantifies the strength of that interaction (Pollard, 2010) . They do not distinguish between agonists and antagonists, or inform on subsequent downstream events in the activation pathway. Additional studies are necessary to explore how the differential binding affinities impact key intermediate events in the TR activation pathway between human and zebrafish. These assays would also inform on whether the observed species differences translate into differential cellular and organism level effects. The identification of species-specific sensitivities to contaminants will aid our understanding of the risk of adverse effects in more sensitive populations. Another limitation to this study is that the TRa paralogs were excluded. Future studies that include both zebrafish TRa paralogs could significantly increase our understanding of the molecular functions and potential evolutionary significance of the duplicate genes. A standardized binding assay for TRb is potentially an effective tool to include in the initial steps of endocrine disruptor screening programs. The assay is a simple and rapid method to screen for chemicals that interact with TRs, and could aid in prioritizing chemicals of concern for further testing and characterization. However, additional development and optimization is necessary to fully characterize assay robustness and reproducibility under varying assay conditions, and to identify potential confounders and sources of bias. For example, as multiple compounds have a lower affinity for zebrafish TRb compared with human, additional work is necessary to determine if zebrafish TRb may be more sensitive to false negatives. Assay confounders can be negated with assay standardization and validation, including receptors from > 1 species, and including additional assays that assess other downstream receptor-mediated endpoints such as protein interaction or target gene expression.
In conclusion, this study assessed how structural variations of 3 common classes of BPCs impact binding affinity for TRb from 2 species. In general, structural variations impacted binding affinities of both receptors in a similar manner. TRb affinity increased with increasing halogen size and decreasing electronegativity, as well as increasing the degree of halogenation. Although many of the calculated affinities were comparable, species differences were identified with the halogenated phenols and many of the bisphenols, possibly due to amino acid differences within the ligand binding domains. The bridge group of diphenyl compounds also influences binding affinities, likely due to varying orientations of the phenyl rings. However, further studies are necessary to explore how the identified structural modifications impact downstream receptor activities and resulting in vivo effects. Understanding how chemicals mimic native thyroid hormones and disrupt normal thyroid signaling is essential to predicting the effects of these chemicals on human and ecosystem health.
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